Home | Inova Search App - Admin

A Randomized Phase 3 Study Evaluating Cystectomy with Perioperative Pembrolizumab and Cystectomy with Perioperative Enfortumab Vedotin and Pembrolizumab versus Cystectomy Alone in Cisplatin-Ineligible Participants with Muscle-Invasive Bladder Cancer

Submitted by centretek on Sat, 10/15/2022 - 10:29
Read more about A Randomized Phase 3 Study Evaluating Cystectomy with Perioperative Pembrolizumab and Cystectomy with Perioperative Enfortumab Vedotin and Pembrolizumab versus Cystectomy Alone in Cisplatin-Ineligible Participants with Muscle-Invasive Bladder Cancer
A Randomized Phase III Study of MRTX849 in Combination with Cetuximab Versus Chemotherapy in Patients with Advanced Colorectal Cancer with KRAS G12C Mutation with Disease Progression On or After Standard First-Line Therapy (MIRATI KRYSTAL-10)

Submitted by centretek on Sat, 10/15/2022 - 10:29
Read more about A Randomized Phase III Study of MRTX849 in Combination with Cetuximab Versus Chemotherapy in Patients with Advanced Colorectal Cancer with KRAS G12C Mutation with Disease Progression On or After Standard First-Line Therapy (MIRATI KRYSTAL-10)
A Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment Naïve Metastatic Pancreatic Cancer (EA2186-GIANT)

Submitted by centretek on Sat, 10/15/2022 - 10:29
Read more about A Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment Naïve Metastatic Pancreatic Cancer (EA2186-GIANT)
Redefining The Use Of a FOLFIRINOX-Like Regimen In the Front Line In Older Patients With Metastatic Pancreatic Cancer (GI 170)

Submitted by centretek on Sat, 10/15/2022 - 10:29
Read more about Redefining The Use Of a FOLFIRINOX-Like Regimen In the Front Line In Older Patients With Metastatic Pancreatic Cancer (GI 170)
RELIEVE-HF Trial: Reducing Lung Congestion Symptoms Using the V-Waveshunt in Advanced Heart Failure

Submitted by centretek on Sat, 10/15/2022 - 10:29
Read more about RELIEVE-HF Trial: Reducing Lung Congestion Symptoms Using the V-Waveshunt in Advanced Heart Failure
Renal Tumors Classification, Biology, and Active Banking Study

Submitted by centretek on Sat, 10/15/2022 - 10:29
Read more about Renal Tumors Classification, Biology, and Active Banking Study
Risk-Stratified Randomized PhaseIII Testing of Blinatumomab (IND#117467, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)

Submitted by centretek on Sat, 10/15/2022 - 10:29
Read more about Risk-Stratified Randomized PhaseIII Testing of Blinatumomab (IND#117467, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome

Submitted by centretek on Sat, 10/15/2022 - 10:29
Read more about Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Selatogrel Outcome Study in suspected Acute Myocardial Infarction (SOS-AMI) Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of self-administered subcutaneous selatogrel

Submitted by centretek on Sat, 10/15/2022 - 10:29
Read more about Selatogrel Outcome Study in suspected Acute Myocardial Infarction (SOS-AMI) Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of self-administered subcutaneous selatogrel
Semaglutide effects on cardiovascular outcomes in people with overweight or obesity (SELECT)

Submitted by centretek on Sat, 10/15/2022 - 10:29
Read more about Semaglutide effects on cardiovascular outcomes in people with overweight or obesity (SELECT)